GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Vaccines, MDPI AG, Vol. 9, No. 6 ( 2021-06-12), p. 643-
    Abstract: Background: This study evaluates the possible effect of 9-valent (9vHPV) vaccination on the results of HPV and cytological tests in a cohort of adult women. Methods: This study is a retrospective, single-cohort, monocentric study. Sexually active women aged 14–70 years, who underwent 9vHPV vaccination, were enrolled. Dose administration dates, side effects and data on Pap smears and HPV tests performed before and after the first vaccine dose were collected. Subjects were considered “unexposed” to the vaccine for all time intervals before the first dose administration, and “exposed” to the first, second and third vaccine doses in all time intervals following each specific dose. Results: A total of 512 women underwent the first 9vHPV dose administration and were enrolled in the study. Median age at vaccination was 30.5 (14–70). Log-rank tests and Cox regression analyses showed a highly statistically significant (p 〈 0.0001) difference in the time to negativization after the exposure to the third vaccine dose in the 207 women starting with a Pap+ smear (HR (95% C.I.), 2.66 (1.83–3.86)) and in the 198 women starting with an HPV HR+ test (HR (95% C.I.), 7.80 (4.83–12.60)). Conclusions: 9vHPV vaccination may play a role in shortening the clearance time of HPV HR+ or Pap positivity in sexually active adult women.
    Type of Medium: Online Resource
    ISSN: 2076-393X
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2703319-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Wiley ; 2016
    In:  United European Gastroenterology Journal Vol. 4, No. 2 ( 2016-04), p. 297-304
    In: United European Gastroenterology Journal, Wiley, Vol. 4, No. 2 ( 2016-04), p. 297-304
    Abstract: Acute abdominal pain (AAP) is one of the most common causes of referral to an emergency department (ED), but information about its impact is limited. Objectives The objectives of this article are to define the prevalence of AAP among ED visits in a large university hospital and analyze its main clinical features. Methods All patients admitted at the Sant’Orsola, Malpighi University Hospital of Bologna ED on 12 a priori selected sample days in 2013 were included. General data were recorded for each patient. A total of 192 clinical variables were recorded for each patient with abdominal pain. Results During the observation period the ED assisted 2623 patients with a daily admission rate of 219 ± 20 (mean ± SD). Of these, 239 patients complained of AAP as their chief complaint at entry (prevalence = 9.1%). AAP prevalence was significantly higher in females than in males (10.4% vs. 7.8%; OR = 1.37; p  = 0.021) as well as in foreign over Italian patients (13.2% vs. 8.5%; OR = 1.64; p  = 0.007). The most frequent ED operative diagnoses were non‐specific abdominal pain ( n  = 86, 36.0%) and gastrointestinal (GI) tract‐related pain ( n  = 79, 33.1%; n  = 19 upper GI, n  = 60 lower GI). Conclusions AAP is a common cause of referral at EDs. Despite technological advances, non‐specific abdominal pain is still the main operative diagnosis.
    Type of Medium: Online Resource
    ISSN: 2050-6406 , 2050-6414
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2728585-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Stem Cell Reports, Elsevier BV, Vol. 13, No. 5 ( 2019-11), p. 847-861
    Type of Medium: Online Resource
    ISSN: 2213-6711
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2019
    detail.hit.zdb_id: 2720528-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Molecular Autism, Springer Science and Business Media LLC, Vol. 11, No. 1 ( 2020-12)
    Abstract: Patients diagnosed with chromosome microdeletions or duplications, known as copy number variants (CNVs), present a unique opportunity to investigate the relationship between patient genotype and cell phenotype. CNVs have high genetic penetrance and give a good correlation between gene locus and patient clinical phenotype. This is especially effective for the study of patients with neurodevelopmental disorders (NDD), including those falling within the autism spectrum disorders (ASD). A key question is whether this correlation between genetics and clinical presentation at the level of the patient can be translated to the cell phenotypes arising from the neurodevelopment of patient induced pluripotent stem cells (iPSCs). Here, we examine how iPSCs derived from ASD patients with an associated CNV inform our understanding of the genetic and biological mechanisms underlying the aetiology of ASD. We consider selection of genetically characterised patient iPSCs; use of appropriate control lines; aspects of human neurocellular biology that can capture in vitro the patient clinical phenotype; and current limitations of patient iPSC-based studies. Finally, we consider how future research may be enhanced to maximise the utility of CNV patients for research of pathological mechanisms or therapeutic targets.
    Type of Medium: Online Resource
    ISSN: 2040-2392
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2540930-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Nature, Springer Science and Business Media LLC, Vol. 587, No. 7834 ( 2020-11-19), p. 377-386
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    EMBO ; 2021
    In:  The EMBO Journal Vol. 40, No. 2 ( 2021-01-15)
    In: The EMBO Journal, EMBO, Vol. 40, No. 2 ( 2021-01-15)
    Type of Medium: Online Resource
    ISSN: 0261-4189 , 1460-2075
    RVK:
    Language: English
    Publisher: EMBO
    Publication Date: 2021
    detail.hit.zdb_id: 1467419-1
    detail.hit.zdb_id: 586044-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2020
    In:  Molecular Autism Vol. 11, No. 1 ( 2020-12)
    In: Molecular Autism, Springer Science and Business Media LLC, Vol. 11, No. 1 ( 2020-12)
    Abstract: The complex pathophysiology of autism spectrum disorder encompasses interactions between genetic and environmental factors. On the one hand, hundreds of genes, converging at the functional level on selective biological domains such as epigenetic regulation and synaptic function, have been identified to be either causative or risk factors of autism. On the other hand, exposure to chemicals that are widespread in the environment, such as endocrine disruptors, has been associated with adverse effects on human health, including neurodevelopmental disorders. Interestingly, experimental results suggest an overlap in the regulatory pathways perturbed by genetic mutations and environmental factors, depicting convergences and complex interplays between genetic susceptibility and toxic insults. The pervasive nature of chemical exposure poses pivotal challenges for neurotoxicological studies, regulatory agencies, and policy makers. This highlights an emerging need of developing new integrative models, including biomonitoring, epidemiology, experimental, and computational tools, able to capture real-life scenarios encompassing the interaction between chronic exposure to mixture of substances and individuals’ genetic backgrounds. In this review, we address the intertwined roles of genetic lesions and environmental insults. Specifically, we outline the transformative potential of stem cell models, coupled with omics analytical approaches at increasingly single cell resolution, as converging tools to experimentally dissect the pathogenic mechanisms underlying neurodevelopmental disorders, as well as to improve developmental neurotoxicology risk assessment.
    Type of Medium: Online Resource
    ISSN: 2040-2392
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2540930-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Frontiers in Cellular Neuroscience, Frontiers Media SA, Vol. 15 ( 2021-10-14)
    Abstract: Myelin is the lipidic insulating structure enwrapping axons and allowing fast saltatory nerve conduction. In the central nervous system, myelin sheath is the result of the complex packaging of multilamellar extensions of oligodendrocyte (OL) membranes. Before reaching myelinating capabilities, OLs undergo a very precise program of differentiation and maturation that starts from OL precursor cells (OPCs). In the last 20 years, the biology of OPCs and their behavior under pathological conditions have been studied through several experimental models. When co-cultured with neurons, OPCs undergo terminal maturation and produce myelin tracts around axons, allowing to investigate myelination in response to exogenous stimuli in a very simple in vitro system. On the other hand, in vivo models more closely reproducing some of the features of human pathophysiology enabled to assess the consequences of demyelination and the molecular mechanisms of remyelination, and they are often used to validate the effect of pharmacological agents. However, they are very complex, and not suitable for large scale drug discovery screening. Recent advances in cell reprogramming, biophysics and bioengineering have allowed impressive improvements in the methodological approaches to study brain physiology and myelination. Rat and mouse OPCs can be replaced by human OPCs obtained by induced pluripotent stem cells (iPSCs) derived from healthy or diseased individuals, thus offering unprecedented possibilities for personalized disease modeling and treatment. OPCs and neural cells can be also artificially assembled, using 3D-printed culture chambers and biomaterial scaffolds, which allow modeling cell-to-cell interactions in a highly controlled manner. Interestingly, scaffold stiffness can be adopted to reproduce the mechanosensory properties assumed by tissues in physiological or pathological conditions. Moreover, the recent development of iPSC-derived 3D brain cultures, called organoids, has made it possible to study key aspects of embryonic brain development, such as neuronal differentiation, maturation and network formation in temporal dynamics that are inaccessible to traditional in vitro cultures. Despite the huge potential of organoids, their application to myelination studies is still in its infancy. In this review, we shall summarize the novel most relevant experimental approaches and their implications for the identification of remyelinating agents for human diseases such as multiple sclerosis.
    Type of Medium: Online Resource
    ISSN: 1662-5102
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2021
    detail.hit.zdb_id: 2452963-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Institute of Electrical and Electronics Engineers (IEEE) ; 2011
    In:  IEEE Transactions on Signal Processing Vol. 59, No. 6 ( 2011-06), p. 2575-2584
    In: IEEE Transactions on Signal Processing, Institute of Electrical and Electronics Engineers (IEEE), Vol. 59, No. 6 ( 2011-06), p. 2575-2584
    Type of Medium: Online Resource
    ISSN: 1053-587X , 1941-0476
    RVK:
    Language: Unknown
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date: 2011
    detail.hit.zdb_id: 2034304-8
    detail.hit.zdb_id: 187297-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Science, American Association for the Advancement of Science (AAAS), Vol. 375, No. 6582 ( 2022-02-18)
    Abstract: Endocrine disrupting chemicals (EDCs) are compounds that interfere with physiological hormonal regulation. Humans are pervasively exposed to many different EDCs, and a growing body of evidence indicates that early life exposure to such EDC mixtures can induce changes in the human organism that underlie increased susceptibility to diseases throughout the life span, including neurodevelopmental disorders. Chemical regulation is, however, entirely based on the risk assessment of individual compounds, leaving the real-life impact of chemical mixtures unexamined and unregulated. This is relevant insofar as cumulative exposure to multiple compounds may be associated with adverse health outcomes even when the concentrations of individual chemicals fall below the regulatory dose. RATIONALE We set out to make the epidemiological associations between exposure to mixtures and health outcomes experimentally tractable, defining molecular pathways and dose responses that could be translated back to actual human exposures and thereby refine current risk assessment practices. As opposed to previous studies that focused on single compounds, we identified and tested an EDC mixture associated with adverse neurodevelopmental outcomes in the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy (SELMA) pregnancy cohort (MIX N) by integrating epidemiological data with experimental toxicology and characterized real life–relevant exposure. RESULTS We used weighted quantile sum (WQS) regression to identify chemicals associated with language delay in children and included those chemicals in MIX N. MIX N was synthesized following the relative proportions and total concentrations found in the SELMA cohort. It was then tested in both in vitro and in vivo models. In human fetal primary neural stem cells and three-dimensional cortical brain organoids differentiated from human pluripotent stem cells, transcriptomic analysis showed that MIX N interferes with hormonal pathways and dysregulates expression of genes and biological pathways that are causally linked to autism spectrum disorders. Data from experiments in Xenopus leavis and Danio rerio , in vivo models validated by the Organisation for Economic Co-operation and Development (OECD), confirmed thyroid function as one of the key and unifying points of vulnerability to MIX N and linked thyroid disruption to neurodevelopmental effects measured as alterations in locomotor activity. The resulting dose-response relationships were then used to estimate a point of departure (POD), which is the toxicological measure to estimate no-effect concentration. This enabled us to apply a similar mixture approach (SMACH) where we (i) identified individuals in the SELMA study who were sufficiently similarly exposed compared with the experimental mixtures and (ii) determined the proportion of the SELMA children with exposure ranges of concern using the POD as reference. CONCLUSION Integrating experimental and epidemiological evidence, we established mechanistic and correlative evidence for neurodevelopmental adversities of an EDC mixture associated with language delay. Using the generated experimental data in a risk assessment concept, we found increased odds of language delay in offspring of up to 54% of pregnant women. These results emphasize the need to take mixtures into account during chemical testing and risk assessment and provide an integrative framework to guide risk assessment strategies. Diagram showing the integrative framework of the study. A mixture of EDCs was associated with adverse neurodevelopmental outcomes in the SELMA pregnancy cohort and was tested in human in vitro and in in vivo models to elucidate the molecular and functional impact of exposure. Experimental data were finally referred back to the cohort for risk assessment by a similar mixture approach. PFAS, perfluoroalkyl substance.
    Type of Medium: Online Resource
    ISSN: 0036-8075 , 1095-9203
    RVK:
    RVK:
    Language: English
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date: 2022
    detail.hit.zdb_id: 128410-1
    detail.hit.zdb_id: 2066996-3
    detail.hit.zdb_id: 2060783-0
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...